Prevention of preterm birth

Seminars in Fetal and Neonatal Medicine

Volumn 17, Issue 1, 2012, Pages 58-63

  Flood, Karen ^a   Malone, Fergal D ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

Preterm birth; Primary prevention; Secondary prevention; Spontaneous

Indexed keywords

ACETYLCYSTEINE; ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; CLINDAMYCIN; FISH OIL; HYDROXYPROGESTERONE CAPROATE; OMEGA 3 FATTY ACID; PLACEBO; PROGESTERONE;

ECONOMIC ASPECT; FETUS DISEASE; HUMAN; INFLAMMATION; NUTRITIONAL STATUS; PATHOPHYSIOLOGY; PATIENT EDUCATION; PREGNANCY OUTCOME; PREMATURE LABOR; PREMATURITY; RECURRENT DISEASE; REVIEW; RISK FACTOR; SMOKING CESSATION; UTERINE CERVIX CERCLAGE; VAGINITIS;

FEMALE; HUMANS; INFANT, NEWBORN; PREGNANCY; PREMATURE BIRTH; RISK FACTORS;

EID: 83555178525     PISSN: 1744165X     EISSN: 18780946     Source Type: Journal    
DOI: 10.1016/j.siny.2011.08.001     Document Type: Review

References (103)

1. Recommended definitions, terminology and format for statistical tables related to the perinatal period and use of a new certificate for cause of perinatal deaths. Modifications recommended by FIGO October 14 1976. Acta Obstet Gynecol Scand 1977, 56:247-253. World Health Organization (WHO).
2. Laws P.J., Graylon N., Sullivan E.A. Australia's mothers and babies 2004 2006, Australian Institute of Health and Welfare, National Perinatal Statistics Unit, Sydney.
3. Martin J.A., Hamilton B.E., Sutton P.D., Ventura S.J., Menacker F., Kirmeyer S. Births: final data for 2004. Natl Vital Stat Rep 2006, 55:1-140.
4. Mattison D.R., Damus K., Fiore E., Petrini J., Alter C. Preterm delivery: a public health perspective. Paediatr Perinat Epidemiol 2001, 15(Suppl. 2):7-16.
5. National Center for Health Statistics. Preliminary births for 2004 []. http://www.cdc.gov/nchs/products/pubs/pubd/hestats/prelimbirths04/prelimbirths04health.htm.
6. Gilbert W.M., Nesbitt T.S., Danielsen B. The cost of prematurity: quantification by gestational age and birth weight. Obstet Gynecol 2003, 102:488-492.
7. Steer P. The epidemiology of preterm labor. BJOG 2005, 112(Suppl. 1):1-3.
8. Wen S.W., Smith G., Yang Q., Walker M. Epidemiology of preterm birth and neonatal outcome. Semin Fetal Neonatal Med 2004, 9:429-435.
9. Kuehn B.M. Groups take aim at US preterm birth rate. JAMA 2006, 296:2907-2908.
10. Tracy S.K., Tracy M.B., Dean J., Laws P.J., Sullivan E.A. Spontaneous preterm birth of liveborn infants in women at low risk in Australia over 10 years: a population-based study. BJOG 2007, 114:731-735.
11. Goldberg R.L., Culhane J.F., Iam J.D., et al. Epidemiology and causes of preterm birth. Lancet 2008, 371:75-84.
12. Kyrgiou M., Koliopoulos G., Martin-Hirsch P., Arbyn M., Prendiville W., Paraskevaidis E. Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet 2006, 367:489-498.
13. Goldenberg R.L., Culhane J.F., Iams J., Romero R. Epidemiology and causes of preterm birth. Lancet 2007, 371:73-82.
14. Meis P.J., Michielutte R., Peters T.J., et al. Factors associated with preterm birth in Cardiff, Wales: II. Indicated and spontaneous preterm birth. Am J Obstet Gynecol 1995, 173:597-602.
15. Steer P.J. The epidemiology of preterm labor - why have advances not equated to reduced incidence?. BJOG 2005, 113(Suppl. 1):1-3.
16. Langhoff-Roos J., Kesmodel U., Jacobsson B., Rasmussen S., Vogel I. Spontaneous preterm delivery in primiparous women at low risk in Denmark: population-based study. BMJ 2006, 332:937-939.
17. Shennan A.H., Bewley S. Why should preterm births be rising?. BMJ 2006, 332:924-925.
18. McCormick C.M. The contribution of low birth weight to infant mortality and childhood morbidity. N Engl J Med 1985, 312:82-90.
19. Lang J.M., Lieberman E., Cohen A. A comparison of risk factors for preterm labor and term small-for-gestational-age birth. Epidemiology 1996, 7:369-376.
20. Scholl T.O., Hediger M.L., Belsky D.H. Prenatal care and maternal health during adolescent pregnancy: a review and meta-analysis. J Adolesc Health 1994, 15:444-456.
21. Prysak M., Lorenz R.P., Kisly A. Pregnancy outcome in nulliparous women 35 years and older. Obstet Gynecol 1995, 85:65-70.
22. Martin J.A., Hamilton B.E., Sutton P.D., et al. Births: final data for 2008. National vital statistics reports 2010, vol. 59. no. 1, National Center for Health Statistics, Hyattsville, MD.
23. Board on Health Sciences Policy. Preterm birth: causes, consequences, and prevention 2006, Committee on Understanding Premature Birth and Assuring Healthy Outcomes, National Academies Press, Washington, DC.
24. Salihu H.M., Mbah A.K., Alio A.P., Clayton H.B., Lynch O. Low pre-pregnancy body mass index and risk of medically indicated versus spontaneous preterm singleton birth. Eur J Obstet Gynecol Reprod Biol 2009, 144:119-123.
25. Han Y.S., Ha E.H., Park H.S., Kim Y.J., Lee S.S. Relationships between pregnancy outcomes, biochemical markers and pre-pregnancy body mass index. Int J Obes (Lond) 2011, 35:570-577.
26. Black R.E., Allen L.H., Bhutta Z.A., Caulfield L.E., de Onis M., Ezzati M., Mathers C., Rivera J. Maternal and child undernutrition: global and regional exposures and health consequences. Lancet 2008, 371(9608):243-260.
27. Tamura T., Goldenberg R.L., Freeberg L.E., Cliver S.P., Cutter G.R., Hoff man H.J. Maternal serum folate and zinc concentrations and their relationships to pregnancy outcome. Am J Clin Nutr 1992, 56:365-370.
28. Hendler I., Goldenberg R.L., Mercer B.M., et al. The Preterm Prediction Study: association between maternal body mass index and spontaneous and indicated preterm birth. Am J Obstet Gynecol 2005, 192:882-886.
29. Scholl T.O. Iron status during pregnancy: setting the stage for mother and infant. Am J Clin Nutr 2005, 81:1218S-1222S.
30. Bukowski R., Malone F.D., Porter F., et al. Preconceptional folate prevents preterm delivery. Am J Obstet Gynecol 2007, 197(6S):3.
31. Kramer M.S. Intrauterine growth and gestational duration determinants. Pediatrics 1987, 80:502-511.
32. Shah N.R., Bracken M.B. A systematic review and meta-analysis of prospective studies in the association between maternal cigarette smoking and preterm delivery. Am J Obstet Gynecol 2000, 182:465-472.
33. Salihu H.M., Pierre-Louis B.J., Alexander G.R. Levels of excess infant deaths attributable to maternal smoking during pregnancy in the United States. Matern Child Health J 2003, 7:219-227.
34. Lumley J., Oliver S.S., Chamberlain C., Oakley L. Interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev (Online) 2004, (4). CD001055.
35. Ancel P.Y., Lelong N., Papiernik E., et al. for EUROPOP. History of induced abortion as a risk factor for preterm birth in European countries: results of the EUROPOP survey. Hum Reprod 2004, 19:734-740.
36. Moreau C., Kaminski M., Ancel P.Y., et al. for the EPIPAGE Group. Previous induced abortions and the risk of very preterm delivery: results of the EPIPAGE study. BJOG 2005, 112:430-437.
37. Sadler L., Saftlas A., Wang W., Exeter M., Whittaker J., McCowan L. Treatment for cervical intraepithelial neoplasia and risk of preterm delivery. JAMA 2004, 291:2100-2106.
38. Jakobsson M., Gissler M., Sainio S., et al. Preterm delivery after surgical treatment for cervical intraepithelial. Obstet Gynecol 2007, 109:309-313.
39. American Congress of Obstetricians and Gynecologists Committee Opinion number 324: perinatal risks associated with assisted reproductive technology. Obstet Gynecol 2005, 106:1143-1146.
40. Bakketeig L.S., Hoffman H.J., Harley E.E. The tendency to repeat gestational age and birth weight in successive births. Am J Obstet Gynecol 1979, 135:1086-1103.
41. Adams M.M., Elam-Evans L.D., Wilson H.G., Gilbertz D.A. Rates and factors associated with recurrence of preterm delivery. JAMA 2000, 283:1591-1596.
42. Bloom S.L., Yost N.P., McIntire D.D., Leveno K.J. Recurrence of preterm birth in singleton and twin pregnancies. Obstet Gynecol 2001, 98:379-385.
43. Berkowitz G., Papiernik E. Epidemiology of preterm birth. Epidemiol Rev 1993, 88:233-238.
44. Goldenberg R.L., Rouse D.J. Prevention of premature birth. N Engl J Med 1998, 339:313-320.
45. Kaminski M., Goujard J., Rumeau-Rouquette C. Prediction of low birthweight and prematurity by a multiple regression analysis with maternal characteristics known since the beginning of the pregnancy. Int J Epidemiol 1973, 2:195-204.
46. Papiernik E., Kaminski M. Multifactorial study of the risk of prematurity at 32 weeks of gestation: a study of the frequency of 30 predictive characteristics. J Perinat Med 1974, 2:30-36.
47. Robinson J.N., Regan J.A., Norwitz E.R. The epidemiology of preterm labor. Semin Perinatol 2001, 25:204-214.
48. Kistka Z.A.F., Palomar L., Lee K.A., Boslaugh S.E., Wangler M.F., Cole F.S., et al. Racial disparity in the frequency of recurrence of preterm birth. Am J Obstet Gynecol 2007, 196:131.e1-131.e6.
49. Petrini J., Callaghan W., Klebanoff M., et al. Estimated effect of 17 alpha hydroxyprogesterone caproate on preterm birth in the United States. Obstet Gynecol 2005, 105:267-272.
50. Mercer B.M., Goldenberg R.L., Moawad A.H., et al. The preterm prediction study: effect of gestational age and cause of preterm birth on subsequent obstetric outcomes. Am J Obstet Gynecol 1999, 181(5 part 1):1216-1221.
51. Carr-Hill R.A., Hall M.H. The repetition of spontaneous preterm labor. BJOG 1985, 92:921-928. 58.
52. Kliegman R.M., Rottman C.J., Behrman R.E. Strategies for the prevention of low birthweight. Am J Obstet Gynecol 1990, 162:1073-1083.
53. Rust O.A., Atlas R.O., Reed J., van Gaalen J., Balducci J. Revisiting the short cervix detected by transvaginal ultrasound in the second trimester: why cerclage therapy may not help. Am J Obstet Gynecol 2001, 185:1098-1105.
54. Drakeley A.J., Roberts D., Alfirevic Z. Cervical stitch (cerclage) for preventing pregnancy loss in women. Cochrane Database Syst Rev 2003, (1). CD003253.
55. Fox N.S., Chervenak F.A. Cervical cerclage: a review of the evidence. Obstet Gynecol Surv 2008, 63:58-65.
56. Spong C.Y. Prediction and prevention of recurrent spontaneous preterm birth. Obstet Gynecol 2007, 110:405-415.
57. Althuisius S.M., Dekker G.A., Hummel P., van Geijn H.P. Cervical incompetence prevention randomized cerclage trial: emergency cerclage with bed rest versus bed rest alone. Am J Obstet Gynecol 2003, 189:907-910.
58. Berghella V., Mackeen A.D. Cervical length screening with ultrasound-indicated cerclage compared with history-indicated cerclage for prevention of preterm birth: a meta-analysis. Obstet Gynecol 2011, 118:148-155.
59. Romero R., Espinoza J., Erez O., Hassan S. The role of cerclage in obstetric practice: can the patient who could benefit from this procedure be identified?. Am J Obstet Gynecol 2006, 194:1-9.
60. Alfirevic Z. Cerclage: we all know how to do it but can't agree when to do it. Obstet Gynecol 2006, 107:219-220.
61. Owen J., Hankins G., Iams J.D., et al. Multicenter randomized trial of cerclage for preterm birth prevention in high-risk women with shortened midtrimester cervical length. Am J Obstet Gynecol 2009, 201:375.e1-375.e8.
62. Berghella V., Odibo A.O., To M.S., Rust O.A., Althuisius S.M. Cerclage for short cervix on ultrasonography, meta-analysis of trials using individual patient-level data. Obstet Gynecol 2005, 106:181-189.
63. Sakai M., Shiozaki A., Tabata M., et al. Evaluation of effectiveness of cerclage of a short cervix according to interleukin-8 in cervical mucus. Am J Obstet Gynecol 2006, 194:14-19.
64. American Congress of Obstetricians and Gynecologists Committee Opinion number 419 October 2008 (replaces no 291, November 2003). Use of progesterone to reduce preterm birth. Obstet Gynecol 2008, 112:963-965.
65. Iams J.D., Romero R., Culhane J.F., Goldenberg R.L. Primary, secondary, and tertiary interventions to reduce the morbidity and mortality of preterm birth. Lancet 2008, 371:164-175.
66. LeVine L. Habitual abortion. A controlled clinical study of progestational therapy. West J Surg 1964, 72:30-36.
67. Fonseca E.B., Celik E., Parra M., Singh M., Nicolaides K.H. Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med 2007, 357:462-469. Fetal Medicine Foundation Second Trimester Screening Group.
68. Meis P.J., Klebanoff M., Thorn E., et al. Prevention of recurrent preterm delivery by 17 alphahydroxyprogesteronecaproate. N Engl J Med 2003, 348:2379-2385.
69. Rouse D.J., Caritis S.N., Peaceman A.M., et al. A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins. N Engl J Med 2007, 357:454-461.
70. Coomarasamy A., Thangaratinam S., Gee H., Khan K.S. Progesterone for the prevention of preterm birth: a critical evaluation of evidence. Eur J Obstet Gynecol Reprod Biol 2006, 129:111-118.
71. Dodd J.M., Crowther C.A., Cincotta R., Flenady V.J., Robinson J.S. Progesterone supplementation for the prevention of preterm birth: a systematic review. Acta Obstet Gynecol Scand 2005, 84:526-533.
72. Dodd J.M., Flenady V.J., Cincotta R., Crowther C.A. Progesterone for the prevention of preterm birth: a systematic review. Obstet Gynecol 2008, 112:127-134.
73. Dodd J.M., Flenady V.J., Cincotta R., Crowther C.A. Prenatal progesterone for prevention of preterm birth. Cochrane Database Syst Rev 2009, [UPDATE].
74. Mackenzie R., Walker M., Armson A., Hannah M.E. Progesterone for the prevention of preterm birth among women at increased risk: a systematic review and meta-analysis of randomized controlled trials. Am J Obstet Gynecol 2006, 194:1234-1242.
75. Sanchez-Ramos L., Kaunitz A.M., Delke I. Progestational agents to prevent preterm birth: a meta-analysis of randomized controlled trials. Am J Obstet Gynecol 2005, 105:273-279.
76. How H.Y., Sibai B.M. Progesterone for the prevention of preterm birth: indications, when to initiate, efficacy and safety. Ther Clin Risk Manag 2009, 5:55-64.
77. Jayasooriva G.S., Lamont R.F. The use of progesterone and other progestational agents to prevent spontaneous preterm labor and preterm birth. Expert Opin Pharmacother 2009, 10:1007-1016.
78. O'Brien J.M., Lewis D.F. Progestins for the prevention of spontaneous preterm birth: review and implications of recent studies. J Reprod Med 2009, 54:73-87.
79. Tita A.T., Rouse D.J. Progesterone for preterm birth prevention: an evolving intervention. Am J Obstet Gynecol 2009, 200:219-224.
80. Bailit J.L., Votruba M.E. Medical cost savings associated with 17 alpha-hydroxyprogesterone caproate. Am J Obstet Gynecol 2007, 196:219.e1-219.e7.
81. Armstrong J. 17 Progesterone for preterm birth prevention: a potential $2 billion pportunity. Am J Obstet Gynecol 2007, 196:194-195.
82. Hassan S.S., Romero R., Vidyadhari D., et al. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol 2011, 38:18-31.
83. Romero R., Gotsch F., Pineles B., Kusanovic J.P. Inflammation in pregnancy: its role in reproductive physiology, obstetrical complications, and fetal injury. Nutr Rev 2007, 65:S194-S202.
84. Christiaens I., Zaragoza D.B., Guilbert L., Robertson S.A., Mitchell B.F., Olson D.M. Inflammatory processes in preterm and term parturition. J Reprod Immunol 2008, 79:50-57.
85. Fredricks D.N., Fiedler T.L., Marrazzo J.M. Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med 2005, 353:1886-1887.
86. McDonald H.M., Brocklehurst P., Gordon A. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev 2007, (1). CD000262.
87. Nygren P., Fu R., Freeman M., Bougatsos C., Klebanoff M., Guise J.M. U.S. Preventive Services Task Force: Evidence on the benefits and harms of screening and treating pregnant women who are asymptomatic for bacterial vaginosis: an update review for the U.S. Preventive Services Task Force. Ann Intern Med 2008, 148:220-233.
88. Screening for bacterial vaginosis in pregnancy to prevent preterm delivery: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008, 148:214-219. U.S. Preventive Services Task Force.
89. Centers for Disease Control and Prevention. Sexually transmitted disease guidelines 2010: Bacterial vaginosis. []. http://www.cdc.gov/std/bv/treatment.htm.
90. Lamont R.F. Can antibiotics prevent preterm birth the pro and con debate. BJOG 2005, 112(Suppl. 1):67-73.
91. Espinoza J., Erez O., Romero R. Preconceptional antibiotic treatment to prevent preterm birth in women with a previous preterm delivery. Am J Obstet Gynecol 2006, 194:630-637.
92. Romero R. Bacterial vaginosis, the inflammatory response and the risk of preterm birth: a role for genetic epidemiology in the prevention of preterm birth. Am J Obstet Gynecol 2004, 190:1509-1519.
93. Romero R., Chaiworapongsa T., Kuivaniemi H., Tromp G. The role of inflammation and infection in preterm birth. Semin Reprod Med 2007, 25:21-39.
94. Shahin A.Y., Hassanin I.M., Ismail A.M., Kruessel J.S., Hirchenhain J. Effect of oral N-acetyl cysteine on recurrent preterm labor following treatment for bacterial vaginosis. Int J Gynaecol Obstet 2009, 104:44-48.
95. Olsen S.F., Joensen H.D. High liveborn birth weights in the Faroes: a comparison between birth weights in the Faroes and in Denmark. J Epidemiol Community Health 1985, 39:27-32.
96. Olsen S.F., Hansen H.S., Sorensen T., et al. Intake of marine fate, risk in (n-3) polyunsaturated fatty acids, may increase birthweight by prolonging gestation. Lancet 1986, 2:367-369.
97. Horvath A., Koletzko B., Szajewska H. Effect of supplementation of women in high-risk pregnancies with long-chain polyunsaturated fatty acids on pregnancy outcomes and growth measures at birth: a meta-analysis of randomized controlled trials. Br J Nutr 2007, 98:253-259.
98. Bulstra-Ramakers M.T., Huisjes H.J., Visser G.H. The effects of 3g eicosapentaenoic acid daily on recurrence of intrauterine growth retardation and pregnancy induced hypertension. Br J Obstet Gynaecol 1995, 102:123-126.
99. Onwude J.L., Lilford R.J., Hjartardottir H., et al. A randomised double blind placebo controlled trial of fish oil in high risk pregnancy. Br J Obstet Gynaecol 1995, 102:95-100.
100. Olsen S.F., Dalby Sorensen J., Secher N.J., et al. Randomised controlled trial of effect of fish-oil supplementation on pregnancy duration. Lancet 1992, 339:1003-1007.
101. Olsen S.F., Sorensen J.D., Secher N.J., et al. Fish oil supplementation and duration of pregnancy. A randomized controlled trial. Ugeskr Laeger 1994, 156:1302-1307.
102. Van Houwelingen A.C., Sorensen J.D., Hornstra G., et al. Essential fatty acid status in neonates after fish-oil supplementation during late pregnancy. Br J Nutr 1995, 74:723-731.
103. Manuck T.A., Henry E., Gibson J., et al. Pregnancy outcomes in a recurrent preterm birth prevention clinic. Am J Obstet Gynecol 2011, 204:320.e1-320.e6.